E. Pogoriler

Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab

J. Wolchok, R. Halaban, J. Allison, 2011, Proceedings of the National Academy of Sciences.

Evaluation of serum IL-17 levels during ipilimumab therapy: Correlation with colitis.

J. Wolchok, J. Allison, M. Callahan, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

CTLA-4 blockade with ipilimumab increases peripheral CD8+ T cells: Correlation with clinical outcomes.

J. Wolchok, A. Yang, Jianda Yuan, 2010 .

CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit

J. Wolchok, J. Allison, N. Segal, 2008, Proceedings of the National Academy of Sciences.